IL326852A - תכשירים להשגת רמות מינון יעילות של מעכבי mtor - Google Patents
תכשירים להשגת רמות מינון יעילות של מעכבי mtorInfo
- Publication number
- IL326852A IL326852A IL326852A IL32685226A IL326852A IL 326852 A IL326852 A IL 326852A IL 326852 A IL326852 A IL 326852A IL 32685226 A IL32685226 A IL 32685226A IL 326852 A IL326852 A IL 326852A
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- effective dose
- dose levels
- mtor inhibitors
- achieving effective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363580027P | 2023-09-01 | 2023-09-01 | |
| PCT/US2024/044577 WO2025049843A1 (en) | 2023-09-01 | 2024-08-30 | Compositions for achieving effective dose levels of mtor inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL326852A true IL326852A (he) | 2026-04-01 |
Family
ID=94820306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL326852A IL326852A (he) | 2023-09-01 | 2024-08-30 | תכשירים להשגת רמות מינון יעילות של מעכבי mtor |
Country Status (5)
| Country | Link |
|---|---|
| CN (1) | CN121772919A (he) |
| AU (1) | AU2024331788A1 (he) |
| IL (1) | IL326852A (he) |
| MX (1) | MX2026002265A (he) |
| WO (1) | WO2025049843A1 (he) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080161324A1 (en) * | 2006-09-14 | 2008-07-03 | Johansen Lisa M | Compositions and methods for treatment of viral diseases |
| US20170354636A1 (en) * | 2015-02-28 | 2017-12-14 | Sequoia Pharmaceuticals, Inc. | Methods for inhibiting tumors and drug resistance |
| US11304954B2 (en) * | 2017-12-19 | 2022-04-19 | Puretech Lyt, Inc. | Lipid prodrugs of mycophenolic acid and uses thereof |
| UY38247A (es) * | 2018-05-30 | 2019-12-31 | Novartis Ag | Anticuerpos frente a entpd2, terapias de combinación y métodos de uso de los anticuerpos y las terapias de combinación |
-
2024
- 2024-08-30 AU AU2024331788A patent/AU2024331788A1/en active Pending
- 2024-08-30 IL IL326852A patent/IL326852A/he unknown
- 2024-08-30 CN CN202480055992.XA patent/CN121772919A/zh active Pending
- 2024-08-30 WO PCT/US2024/044577 patent/WO2025049843A1/en active Pending
-
2026
- 2026-02-25 MX MX2026002265A patent/MX2026002265A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2024331788A1 (en) | 2026-02-26 |
| CN121772919A (zh) | 2026-03-31 |
| WO2025049843A1 (en) | 2025-03-06 |
| MX2026002265A (es) | 2026-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL318748A (he) | הרכבים ושיטות לעיכוב kras | |
| IL317985A (he) | תכשירים פרמצבטיים הכוללים מעכבי הליקס של wrn | |
| CR20240382A (es) | ANÁLOGOS DE RAPAMICINA A C40, C28 Y C32 COMO INHIBIDORES DE MTOR (Divisional 2020-578) | |
| IL317988A (he) | תכשירים פרמצבטיים הכוללים מעכבי הליקס של | |
| IL317736A (he) | תרכובות כמעכבות של axl | |
| IL291453A (he) | צורות מינון עבור מעכבי tyk2 | |
| IL320739A (he) | מעכבי rock2 | |
| EP4448514A4 (en) | TYK2 INHIBITORS AND ASSOCIATED COMPOSITIONS AND PROCESSES | |
| PL4284511T3 (pl) | Azachinoliny jako inhibitory cd38 | |
| IL320892A (he) | תכשירי רוקחות לטיפול או מניעה של עמילואידוזיס בתיווך טרנסתירטין | |
| IL314824A (he) | פורמולציה משולבת של סדאזורידין | |
| IL325596A (he) | תכשירי רוקחות למעכבים של nek7 קינאז | |
| IL317433A (he) | תרכובות לטיפול ב- xlmtm | |
| SI4214210T1 (sl) | Spojine in sestavki kot zaviralci sppl2a | |
| KR102434191B9 (ko) | 화재확산방지를 위한 보호 외함 | |
| IL316843A (he) | תרכובות ושיטות לעיכוב ביטול של snca | |
| GB202208022D0 (en) | Therapeutic compounds and compositions | |
| IL313703A (he) | תכשירים לטיפול בדלקת | |
| CA3297265A1 (en) | Pharmaceutical compositions for inhibitors of nek7 kinase | |
| IL325331A (he) | מעכבים של tyk2, תכשירים המכילים אותם ושימושיהם | |
| CA3276315A1 (en) | Composition for preventing or treating side effects of cholinesterase inhibitors | |
| CA3293535A1 (en) | Inhibitors of tyk2 | |
| CA3273897A1 (en) | Inhibitors of tyk2 | |
| GB202501591D0 (en) | Compositions for treatment of ear conditions | |
| CA3298237A1 (en) | Methods of treating difluoropropene compositions |